戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 arance for the direct detection of MRSA from nasal swabs.
2 ultures of the acute-phase serum samples and nasal swabs.
3 ected by vaginal swabs compared to rectal or nasal swabs.
4 s identified by axillary samples paired with nasal swabs.
5 ee stools (0.3%) and for the first time in a nasal swab (0.1%).
6  a modest prevalence of M. bovis shedding in nasal swabs (2.9%) and milk (1.4%) and of B. abortus in
7 n oropharyngeal swab, compared with use of a nasal swab alone, increased the frequency of detection o
8 haryngeal swabs, compared with collection of nasal swabs alone, for detection of common respiratory v
9 steurella multocida were isolated by using a nasal swab and a transtracheal swab from individual calv
10 e similarity of the isolates obtained from a nasal swab and from a transtracheal swab was compared by
11       Cytology of nasal smear by taking with nasal swab and Hansel's staining was performed.
12                                              Nasal swab and serum samples were collected prior to ons
13 solation of DNA from an anthrax spore-spiked nasal swab and the subsequent on-chip amplification of t
14               We performed nasopharyngeal or nasal swabbing and/or serum sampling (n = 148) in Lancas
15 orrelated with a reduction in viral titer in nasal swabs and lungs, following challenge with H1N1 pan
16 were assessed by determining virus titers in nasal swabs and respiratory tissues, which were also use
17                Regular bacterial analyses of nasal swabs and sputum were performed, and clinical even
18 ble rapid broad-spectrum pathogen testing on nasal swabs and therefore allow implementation of infect
19 e initial evaluation consisted of 403 paired nasal swabs and was done using the specimen preparation
20 ive isolation of B. parapertussis from ovine nasal swabs and, in successfully excluding overgrowth wi
21  determined by culturing ear, umbilicus, and nasal swabs, and (iii) the distribution of GBS serotypes
22  was 85% with nasopharyngeal swabs, 78% with nasal swabs, and 69% with nasopharyngeal washes.
23 ch as blood, probang samples, and saliva and nasal swabs, and herd-level samples, such as air samples
24 e-motif 21 (TRIM21) messenger RNA indexes in nasal swabs as potential biomarkers of viral respiratory
25  was associated with a positive culture from nasal swabs at discharge.
26 virus-associated RTI episodes confirmed from nasal swabs by using nucleic acid testing.
27 rmed by using 16S rDNA pyrosequencing of 872 nasal swabs collected biweekly from 47 unselected infant
28           In addition, IBV was detected in 3 nasal swabs collected from PRRSV-seropositive pigs by re
29                                              Nasal swabs collected from the patient and from one of h
30                 These results suggest that a nasal swab culture can be predictive of the bacterial pa
31 individuals) provided concurrent symptom and nasal swab data for 4166 person-weeks.
32 ty symptomatic pilgrims underwent additional nasal swabs during their pilgrimage in the KSA, of which
33 tional study were interviewed and provided a nasal swab for S. aureus analysis.
34 rmance of nasopharyngeal, oropharyngeal, and nasal swabs for the detection of influenza virus using r
35        We examined the children and obtained nasal swabs for the detection of RSV during each respira
36  visits were made to identify ARI and obtain nasal swabs for viral detection using real-time reverse-
37          Nasal lavage for flow cytometry and nasal swabs for viral PCR were performed at enrollment a
38 arriage were screened with eight consecutive nasal swabs (four standard rayon, four charcoal-coated r
39                                              Nasal swabs from 11 of 17 (65%) employees tested positiv
40  Human coronavirus was detected by RT-PCR in nasal swabs from 3 of 20 patients but in no sinus secret
41 axillary aspirates from 8 (40%) patients and nasal swabs from 9 (45%) patients, by reverse transcript
42 ective ability of MBM was evaluated with 200 nasal swabs from conventionally reared sheep, and B. par
43 tively collecting weekly symptom diaries and nasal swabs from families for 1 year, (2) analyzed data
44                                              Nasal swabs from patients positive by Xpert MRSA PCR and
45         Home visits were conducted to obtain nasal swabs from persons with ARI/ILI.
46 rlpools and taping gel and from 35 of the 84 nasal swabs from players and staff members (42 percent).
47                        IBV was detected in 3 nasal swabs from PRRSV-seropositive pigs by real-time re
48 h 84 primary isolation plates generated from nasal swabs from swine with clinical signs of atrophic r
49 ly ill patients and also being asked to test nasal swabs from the potentially exposed.
50 ms for a year and collected 4,190 individual nasal swabs from three distinct pig subpopulations.
51                                              Nasal swabs had equal or greater sensitivity than oropha
52  samples were bacteriologically positive the nasal swab identified the same bacterial species as the
53                                          The nasal swab isolate was genetically identical to the tran
54              One hundred percent of archival nasal swab lysates yielded the expected PCR results when
55 4 weeks, facilitating detection of MRSA from nasal swab lysates, and may decrease the amount of unuse
56 NxG assay with prospectively collected rayon nasal swabs (n = 1,103) and flocked swab (ESwab) nasal s
57 ntained milk from 10 animals and in 56.2% of nasal swabs (n = 121) from cattle from tuberculin test-p
58 re, a simplified collection approach using a nasal swab (NS) is described.
59                          Self-collected foam nasal swabs (NS) obtained after instillation of saline s
60    The prospective study collected MRSA from nasal swabbing of residents of 26 nursing homes in Orang
61 rich and sequence viral nucleic acids in the nasal swabs of 50 young dairy cattle with symptoms of BR
62  was, however, isolated from the tonsils and nasal swabs of the asymptomatic T15 pigs at 26 days post
63 Thirty-one carriers had two or more positive nasal swabs; of these, the isolates in all swabs from a
64   This assay can detect SPPV in buffy coats, nasal swabs, oral swabs, scabs, and skin lesions as well
65 y tract infections based on parent-collected nasal swabs over the winter months.
66                            Virus titers from nasal swabs peaked on day 2, and low titers were detecte
67           Compared to PCR, direct plating of nasal swabs performed poorly, especially for patients wi
68  Here, we assessed the concordance of paired nasal swabs processed using commercial PCR and culture a
69 apertussis in conventionally reared sheep by nasal swabbing proved futile with existing selective med
70 ins of the H3N8 subtype were evaluated using nasal swabs received for routine diagnosis and swabs col
71 Matching criteria were center, date of first nasal swab sample, and exposure time.
72 detect H3N2 IAVs directly from nasal wash or nasal swab samples collected from laboratory-challenged
73 hildren's Hospital; clinical staff collected nasal swab samples from 25 patients and then operated te
74 rthermore, we analysed by BuV qPCR stool and nasal swab samples from 955 children with gastroenteriti
75                 We performed HBoV testing on nasal swab samples from a prospective, longitudinal stud
76          The sensitivity of this test, using nasal swab samples taken from both symptomatic and asymp
77 influenza or respiratory syncytial virus had nasal swab samples tested for rhinovirus, coronavirus OC
78                                 Twenty-three nasal swab samples that tested positive for methicillin-
79                               Patients whose nasal swab samples were always negative served as contro
80                                              Nasal swab samples were collected during respiratory ill
81 icity and other adverse events and blood and nasal swab samples were obtained following vaccination.
82 ng HHCs were as follows: 49% (51 of 104) for nasal swab samples, 53.8% (56 of 104) for nasal biopsy s
83 ty among patients were 66.4% (75 of 113) for nasal swab samples, 71.7% (81 of 113) for nasal turbinat
84 re screened for spore exposure by collecting nasal swab samples.
85 cts recorded symptoms and provided blood and nasal swab samples.
86         Our results suggest that large-scale nasal-swab screening for potential exposure to anthrax s
87 lonized patients would have been missed with nasal swab specimen culture only.
88 ates but are rather common human isolates, a nasal swab specimen for culture was collected voluntaril
89 or the rapid detection of MRSA directly from nasal swab specimens (IDI-MRSA; Infectio Diagnostic, Inc
90 study (traditional medium used, SBA) and 667 nasal swab specimens from MCW (traditional medium used,
91                          For this study, 767 nasal swab specimens from the multicenter study (traditi
92 identification of MRSA strains directly from nasal swab specimens taken from the anterior nares.
93 tein-based detection of influenza virus from nasal swab specimens was developed and evaluated in a cl
94 ruses A and B and adenoviruses (AdV), paired nasal swab specimens were collected from 384 recruits wi
95                                       Paired nasal swab specimens were collected from patients who we
96                                   Throat and nasal swab specimens were collected, combined, and teste
97                                        Three nasal swab specimens were obtained 1 month apart on ente
98             A total of 515 compliant remnant nasal swab specimens were sequentially used to inoculate
99  assay for the direct detection of MRSA from nasal swab specimens.
100 l, Lenexa, KS), for the detection of MRSA in nasal swab specimens.
101 e conducted a retrospective cohort study and nasal-swab survey of 84 St.
102        The median time from symptom onset to nasal swab was 2 days; 65.4% of samples were positive fo
103                                            A nasal swab was positive for S. aureus on at least one oc
104 sideration of results from oropharyngeal and nasal swabs was as effective as consideration of results
105  signs of FMD, viremia, or viral shedding in nasal swabs was found in the Ad5-boIFN-lambda3-treated a
106 -resistant Staphylococcus aureus (MRSA) from nasal swabs, was evaluated in this multicenter study for
107 in-resistant Staphylococcus aureus (MRSA) in nasal swabs, we compared BD GeneOhm MRSA PCR and various
108  and RT-PCR identification of influenza from nasal swabs, we tracked the course of seasonal and pande
109                                              Nasal swabs were collected at respiratory illness onset
110                                      Flocked nasal swabs were collected during 3 influenza seasons (2
111                                              Nasal swabs were collected from participants and tested
112                                              Nasal swabs were obtained at ICU admission and weekly th
113          Thirty-seven ocular, urogenital, or nasal swabs were obtained from 21 wild western barred ba
114                                              Nasal swabs were obtained from a national cohort of midd
115  188 children with nasal discharge, 64 (34%) nasal swabs were PCR positive.
116                                              Nasal swabs were taken from health-care workers every 4
117 irs completed a questionnaire and provided a nasal swab which was analyzed for S. aureus, methicillin
118                         Tracheal wash fluid, nasal swabs, whole blood samples, and serum samples from
119 us virus were 2 to 3 logs lower in ocular or nasal swabs with 51g than with 51gR.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top